Evidence map›Paper›PMID 19742190›Full record

ArticleIndian journal of psychiatry2009

The prevention and treatment of cognitive decline and dementia: An overview of recent research on experimental treatments.

Chittaranjan Andrade, Rajiv Radhakrishnan

Open access · diamondAbstract read
In one paragraph

Article in Indian journal of psychiatry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 88 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Cognitive stimulation in a-MCI: an experimental study.American journal of Alzheimer's disease and other dementias · 2012
    Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Dementia and Cognitive Decline in Older Adulthood: Are Agricultural Workers at Greater Risk?The journals of gerontology. Series B, Psychological sciences and social sciences · 2021
    Article
  16. Drug therapies for chronic conditions and risk of Alzheimer's disease and related dementias: A scoping review.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2021
    Article
  17. Diet Associated with Inflammation and Alzheimer's Disease.Journal of Alzheimer's disease reports · 2019
    Review
  18. Synergistic Neuroprotective Effect ofInternational journal of molecular sciences · 2019
    Article
  19. Article
  20. Dissecting the Potential Roles ofFrontiers in aging neuroscience · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Chittaranjan AndradeDepartment of Psychopharmacology, National Institute of Mental Health and Neurosciences, Bangalore - 560 029, India.
Rajiv Radhakrishnan
National Institute of Mental Health and Neurosciences · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prevention and treatment of cognitive impairment in the elderly has assumed increasing importance in an aging population. This article presents a qualitative review of recent research on experimental interventions for the prevention and treatment of mild cognitive impairment and Alzheimer's disease in elderly subjects. Interventions addressed range from lifestyle measures to pharmacological treatments. Epidemiological studies suggest that dietary measures, physical exercise, and mental activity may reduce the risk of cognitive impairment and Alzheimer's disease in elderly subjects. Statins may protect against incident dementia, and lithium may convey similar benefits to bipolar patients. Ginkgo appears ineffective as a primary preventive measure. Donepezil but not Vitamin E may benefit persons with mild cognitive impairment. Experimental treatments potentially useful for Alzheimer's disease include dimebon, PBT2 and etanercept; the safety and efficacy of the Alzheimer's vaccine remains to be proven, and growth hormone secretagogue and tarenflurbil are likely ineffective. Herbal treatments merit study in elderly subjects with cognitive syndromes.

Indexed as

Alzheimer's diseasecognitiondementiaelderlyMild cognitive impairment

Identifiers

PMID19742190
PMCPMC2738400
OpenAlexW2015335341

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.